Close Menu

NEW YORK – In vitro diagnostic company Todos Medical said Tuesday it has inked a non-exclusive agreement for distribution in the US and Israel of 3D Medicines' 3DMed 2019-nCoV Detection Kit, 3DMed 2019-nCoV & Flu A/B Detection Kit, and Andis350 3DMed Automated Solution real-time PCR machine.

The testing products, developed by China-based 3D Medicines, have received CE marking and approval from the Chinese National Medical Products Administration, according to Rehovot, Israel-based Todos.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.